E. Merck's Annual Report of Recent Advances in Pharmaceutical Chemistry and Therapeutics, 1912, Vol. 25 (Classic Reprint)

E. Merck's Annual Report of Recent Advances in Pharmaceutical Chemistry and Therapeutics, 1912, Vol. 25 (Classic Reprint)

Author: E. Merck

Publisher:

Published: 2015-07-21

Total Pages: 520

ISBN-13: 9781331946427

DOWNLOAD EBOOK

Excerpt from E. Merck's Annual Report of Recent Advances in Pharmaceutical Chemistry and Therapeutics, 1912, Vol. 25 As far back as 1870 I undertook to furnish my friends and customers with short reports on recent therapeutic preparations, as at that time the professional journals did not contain as detailed and complete accounts of recent discoveries in the field of pharmacotherapy as is now the case. These communications, which appeared at irregular intervals, developed in the course of years into the regular Annual Report. Its aim from the first was to collect the most important items from the entire international literature, all the information that was likely to prove of interest to physicians and pharmacists, and to present it in a perfectly, impartial manner, leaving the reader to examine the information and to decide upon its actual value. I have therefore scrupulously avoided expressing my own views upon the results obtained by others, provided these communications did not conceal some actual danger, to which it was absolutely necessary to draw attention. On account of this impartiality, combined with as comprehensive a report as possible, the Annual Report has been so highly appreciated that the number of copies printed has had to be increased from year to year. At the present time it is published in four languages (German, English, French and Russian), the total annual edition amounting to 60,000 copies. This steady increase of the annual edition is evidence that the Annual Report supplies a real want. Further, it bears eloquent testimony that the Annual Report has succeeded in satisfying its readers. In accordance with the purely scientific object of the Annual Report, only those new preparations and drugs have been discussed which have been introduced into therapeutics as a result of scientific research, while secret remedies and scientifically questionable preparations have been excluded as far as possible. Thus doubtful preparations will not receive unmerited recognition, such as might result from their mention in the Annual Report, which is held in such high esteem. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.


E. Merck's Annual Report, Vol. 24: Of Recent Advances in Pharmaceutical Chemistry and Therapeutics (Classic Reprint)

E. Merck's Annual Report, Vol. 24: Of Recent Advances in Pharmaceutical Chemistry and Therapeutics (Classic Reprint)

Author:

Publisher: Forgotten Books

Published: 2015-07-12

Total Pages: 426

ISBN-13: 9781331250456

DOWNLOAD EBOOK

Excerpt from E. Merck's Annual Report, Vol. 24: Of Recent Advances in Pharmaceutical Chemistry and Therapeutics The naturally occurring compounds of arsenium, particularly white arsenic, have always played a rather important role in the treatment of various skin diseases, and ascosmetics. It has remained for the investigators of thelast hundred years to throw more light on the physiological mode of action of arsenium and of its derivatives. With the gain in our knowledge of the therapeutic value of arsenium compounds, the ill effects of arsenic treatment were also brought to light, and it was shown that the successful treatment of obstinate skin diseases requires the use of such considerable doses of the inorganic arsenic preparations as to produce appreciable injury to the organism as a whole, or to special parts of it. Thus among the secondary effects following the use of arsenic many cases have been observed) of changes in the skin, such as dermatitis, erythema, pigmentation and shedding of hair, also affections of the internal organs, including the mucous membrane of the throat, nose and eyes, also frequent disturbances of the kidneys and of the central nervous system. An attempt was consequently made to use organic compounds of arsenium, and by their agency to administer large and effective doses of arsenium, practically freefrom any toxic action; this was achieved by the use of the salts of cacodylic acid. These salts quickly took a firm place in therapeutics, and they have held their ground in spite of the introduction of newer preparations of arsenium, for they rarely produce any harmful secondary effects, nor do they subject the patient to the risk of dangerous permanent injury, such as complete blindness, as has been observed to follow the use of other organic compounds of arsenium. The chemistry of the cacodylates and of cacodyle was fully studied by Bunsen. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.


E. Merck's Annual Report, Vol. 26

E. Merck's Annual Report, Vol. 26

Author:

Publisher:

Published: 2015-07-21

Total Pages: 552

ISBN-13: 9781331946342

DOWNLOAD EBOOK

Excerpt from E. Merck's Annual Report, Vol. 26: Of Recent Advances in Pharmaceutical Chemistry and Therapeutics In the economy of living cells belonging to the vegetable and animal kingdoms, a very important part is played by a certain group of bodies, which are generally spoken of collectively as "lipoids"). Among the best known members of this group are the cholesterins and lecithins. While the cholesterins are organic combinations free from nitrogen and phosphorus, the lecithins contain both nitrogen and phosphorus. They are grouped together as a special class of bodies, the so-called "phosphatides"), comprising a large number of representatives. The phosphatides are characterised by containing one or more molecules of phosphoric acid, an alcohol (for example glycerin), one or more fatty acid radicles (for example stearic or oleic acid) and one or more nitrogenous bodies (such as choline and allied substances). Lecithin, or rather the lecithins, are phosphatides of this description. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.


E. Merck's Annual Report, Vol. 27

E. Merck's Annual Report, Vol. 27

Author:

Publisher: Forgotten Books

Published: 2017-12-26

Total Pages: 594

ISBN-13: 9780484855747

DOWNLOAD EBOOK

Excerpt from E. Merck's Annual Report, Vol. 27: Of Recent Advances in Pharmaceutical Chemistry and Therapeutics Som m ers expressed himself in the following terms with regard to nuclein: Nuclein, which is deposited by the leuco cytes in the cells in the organism, is the carrier of the antitoxic properties of the organism and its therapeutic use has frequently yielded good results in carcinoma, tuberculosis, pernicious anaemia, angina, diphtheria, marasmus, cachexia, and inflammatory infectious and asthenic -processes*. He re commends the internal administration of the preparation in the form of powders or tablets. For this purpose the follow ing prescriptions may be used. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.


Merck's Annual Report of Recent Advances in Pharmaceutical Chemistry and Therapeutics

Merck's Annual Report of Recent Advances in Pharmaceutical Chemistry and Therapeutics

Author: Anonymous

Publisher: Arkose Press

Published: 2015-10-31

Total Pages: 600

ISBN-13: 9781345703566

DOWNLOAD EBOOK

This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.